EE+ POEM Archive
Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues
Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Aducanumab Is Not Effective for Mild Cognitive Impairment or Mild Alzheimer's Dementia and Has Major Safety Issues." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315621/all/Aducanumab_is_not_effective_for_mild_cognitive_impairment_or_mild_Alzheimer's_dementia_and_has_major_safety_issues.
Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315621/all/Aducanumab_is_not_effective_for_mild_cognitive_impairment_or_mild_Alzheimer's_dementia_and_has_major_safety_issues. Accessed March 31, 2023.
Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315621/all/Aducanumab_is_not_effective_for_mild_cognitive_impairment_or_mild_Alzheimer's_dementia_and_has_major_safety_issues
Aducanumab Is Not Effective for Mild Cognitive Impairment or Mild Alzheimer's Dementia and Has Major Safety Issues [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315621/all/Aducanumab_is_not_effective_for_mild_cognitive_impairment_or_mild_Alzheimer's_dementia_and_has_major_safety_issues.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aducanumab is not effective for mild cognitive impairment or mild Alzheimer's dementia and has major safety issues
ID - 1315621
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315621/all/Aducanumab_is_not_effective_for_mild_cognitive_impairment_or_mild_Alzheimer's_dementia_and_has_major_safety_issues
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
